176 related articles for article (PubMed ID: 22928166)
1. Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood.
Darlington DN; Kremenevskiy I; Pusateri AE; Scherer MR; Fedyk CG; Kheirabaldi BS; Delgado AV; Dubick MA
Int J Burns Trauma; 2012; 2(1):42-50. PubMed ID: 22928166
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
[TBL] [Abstract][Full Text] [Related]
3. Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro.
Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
Anesth Analg; 2020 Apr; 130(4):1063-1076. PubMed ID: 31609256
[TBL] [Abstract][Full Text] [Related]
4. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
[TBL] [Abstract][Full Text] [Related]
5. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits.
Kheirabadi BS; Crissey JM; Deguzman R; Perez MR; Cox AB; Dubick MA; Holcomb JB
J Trauma; 2008 May; 64(5):1218-28; discussion 1228-9. PubMed ID: 18469644
[TBL] [Abstract][Full Text] [Related]
6. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
[TBL] [Abstract][Full Text] [Related]
7. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
Viuff D; Lauritzen B; Pusateri AE; Andersen S; Rojkjaer R; Johansson PI
Br J Anaesth; 2008 Sep; 101(3):324-31. PubMed ID: 18565966
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
[TBL] [Abstract][Full Text] [Related]
9. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
10. Freeze-dried plasma mitigates the dilution effects of a hemoglobin-based oxygen carrier (HBOC-201) in a model of resuscitation for hemorrhage and hemodilution.
Meledeo MA; Peltier GC; McIntosh CS; Taylor AS; Bynum JA; Pusateri AE; Cap AP
J Trauma Acute Care Surg; 2019 Jul; 87(1S Suppl 1):S83-S90. PubMed ID: 31246911
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Dickneite G; Dörr B; Kaspereit F; Tanaka KA
J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
[TBL] [Abstract][Full Text] [Related]
12. An in vitro study comparing the effects of Hextend, Hespan, normal saline, and lactated ringer's solution on thrombelastography and the activated partial thromboplastin time.
Dailey SE; Dysart CB; Langan DR; Slye MJ; Nuttall GA; Schrader LM; Williams BA; Oliver WC
J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):358-61. PubMed ID: 16130064
[TBL] [Abstract][Full Text] [Related]
13. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time.
Kheirabadi BS; Crissey JM; Deguzman R; Holcomb JB
J Trauma; 2007 Jun; 62(6):1352-9; discussion 1359-61. PubMed ID: 17563647
[TBL] [Abstract][Full Text] [Related]
14. Does Hextend impair coagulation compared to 6% hetastarch? An ex vivo thromboelastography study.
Weeks DL; Jahr JS; Lim JC; Butch AW; Driessen B
Am J Ther; 2008; 15(3):225-30. PubMed ID: 18496260
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.
Hendriks HG; Meijer K; de Wolf JT; Porte RJ; Klompmaker IJ; Lip H; Slooff MJ; van der Meer J
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):309-13. PubMed ID: 12032396
[TBL] [Abstract][Full Text] [Related]
16. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.
Godier A; Mazoyer E; Cymbalista F; Cupa M; Samama CM
J Thromb Haemost; 2007 Feb; 5(2):244-9. PubMed ID: 17129221
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of the effects of reduced temperature on thrombin generation: the contributions of hypothermia to coagulopathy.
Mitrophanov AY; Rosendaal FR; Reifman J
Anesth Analg; 2013 Sep; 117(3):565-574. PubMed ID: 23868891
[TBL] [Abstract][Full Text] [Related]
19. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin and activated partial thromboplastin times, thromboelastography, hematocrit, and platelet count in a feline hemorrhage/over-resuscitation model using lactated Ringer's solution or 6% tetrastarch 130/0.4.
Zeiler GE; Dzikiti BT; Rioja E; Kamerman P; Buck RK; Pohlin F; Fuller A
J Vet Emerg Crit Care (San Antonio); 2024 Jun; ():. PubMed ID: 38874122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
